Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death

Young Do Yoo, Young Min Chung, Jong Kuk Park, Chul Min Ahn, Sung Kyu Kim, Hyung Jung Kim

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Peroxiredoxin II (Prx II) is known not only to protect cells from oxidative damage caused by hydrogen peroxide (H2O2), but also to endow cancer cells with resistance to both H2O2 and cisplatin and to grant them radioresistance. In this study, we examined whether Prx II antisense could enhance cisplatin-induced cell death. When gastric cancer cells were transfected with various concentrations of Prx II antisense plasmid, pPrxII/AS, and then treated with the same concentrations of cisplatin, Prx II antisense enhanced cisplatin-induced cell death. The combination index (CI) at all doses of the combination was below 1, indicating that Prx II antisense sensitized cisplatin-induced cell death. This synergism was also observed in the cells transfected with a Prx II antisense oligomer. Our present results, therefore, suggest that Prx II antisense would be a very good sensitizer for cisplatin, and that Prx II as a target for chemosensitizers constitutes a promising avenue for future research.

Original languageEnglish
Pages (from-to)273-277
Number of pages5
JournalExperimental and Molecular Medicine
Volume34
Issue number4
Publication statusPublished - 2002 Sep 30

Fingerprint

Peroxiredoxins
Cell death
Cisplatin
Cell Death
Cells
Oligomers
Hydrogen Peroxide
Stomach Neoplasms
Plasmids

Keywords

  • Antisense
  • Chemosensitizer
  • Cisplatin
  • Multidrug resistance
  • Prx II

ASJC Scopus subject areas

  • Biochemistry
  • Genetics

Cite this

Yoo, Y. D., Chung, Y. M., Park, J. K., Ahn, C. M., Kim, S. K., & Kim, H. J. (2002). Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death. Experimental and Molecular Medicine, 34(4), 273-277.

Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death. / Yoo, Young Do; Chung, Young Min; Park, Jong Kuk; Ahn, Chul Min; Kim, Sung Kyu; Kim, Hyung Jung.

In: Experimental and Molecular Medicine, Vol. 34, No. 4, 30.09.2002, p. 273-277.

Research output: Contribution to journalArticle

Yoo, YD, Chung, YM, Park, JK, Ahn, CM, Kim, SK & Kim, HJ 2002, 'Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death', Experimental and Molecular Medicine, vol. 34, no. 4, pp. 273-277.
Yoo, Young Do ; Chung, Young Min ; Park, Jong Kuk ; Ahn, Chul Min ; Kim, Sung Kyu ; Kim, Hyung Jung. / Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death. In: Experimental and Molecular Medicine. 2002 ; Vol. 34, No. 4. pp. 273-277.
@article{663441afb63e4e1db3e6f701993e21c8,
title = "Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death",
abstract = "Peroxiredoxin II (Prx II) is known not only to protect cells from oxidative damage caused by hydrogen peroxide (H2O2), but also to endow cancer cells with resistance to both H2O2 and cisplatin and to grant them radioresistance. In this study, we examined whether Prx II antisense could enhance cisplatin-induced cell death. When gastric cancer cells were transfected with various concentrations of Prx II antisense plasmid, pPrxII/AS, and then treated with the same concentrations of cisplatin, Prx II antisense enhanced cisplatin-induced cell death. The combination index (CI) at all doses of the combination was below 1, indicating that Prx II antisense sensitized cisplatin-induced cell death. This synergism was also observed in the cells transfected with a Prx II antisense oligomer. Our present results, therefore, suggest that Prx II antisense would be a very good sensitizer for cisplatin, and that Prx II as a target for chemosensitizers constitutes a promising avenue for future research.",
keywords = "Antisense, Chemosensitizer, Cisplatin, Multidrug resistance, Prx II",
author = "Yoo, {Young Do} and Chung, {Young Min} and Park, {Jong Kuk} and Ahn, {Chul Min} and Kim, {Sung Kyu} and Kim, {Hyung Jung}",
year = "2002",
month = "9",
day = "30",
language = "English",
volume = "34",
pages = "273--277",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "4",

}

TY - JOUR

T1 - Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death

AU - Yoo, Young Do

AU - Chung, Young Min

AU - Park, Jong Kuk

AU - Ahn, Chul Min

AU - Kim, Sung Kyu

AU - Kim, Hyung Jung

PY - 2002/9/30

Y1 - 2002/9/30

N2 - Peroxiredoxin II (Prx II) is known not only to protect cells from oxidative damage caused by hydrogen peroxide (H2O2), but also to endow cancer cells with resistance to both H2O2 and cisplatin and to grant them radioresistance. In this study, we examined whether Prx II antisense could enhance cisplatin-induced cell death. When gastric cancer cells were transfected with various concentrations of Prx II antisense plasmid, pPrxII/AS, and then treated with the same concentrations of cisplatin, Prx II antisense enhanced cisplatin-induced cell death. The combination index (CI) at all doses of the combination was below 1, indicating that Prx II antisense sensitized cisplatin-induced cell death. This synergism was also observed in the cells transfected with a Prx II antisense oligomer. Our present results, therefore, suggest that Prx II antisense would be a very good sensitizer for cisplatin, and that Prx II as a target for chemosensitizers constitutes a promising avenue for future research.

AB - Peroxiredoxin II (Prx II) is known not only to protect cells from oxidative damage caused by hydrogen peroxide (H2O2), but also to endow cancer cells with resistance to both H2O2 and cisplatin and to grant them radioresistance. In this study, we examined whether Prx II antisense could enhance cisplatin-induced cell death. When gastric cancer cells were transfected with various concentrations of Prx II antisense plasmid, pPrxII/AS, and then treated with the same concentrations of cisplatin, Prx II antisense enhanced cisplatin-induced cell death. The combination index (CI) at all doses of the combination was below 1, indicating that Prx II antisense sensitized cisplatin-induced cell death. This synergism was also observed in the cells transfected with a Prx II antisense oligomer. Our present results, therefore, suggest that Prx II antisense would be a very good sensitizer for cisplatin, and that Prx II as a target for chemosensitizers constitutes a promising avenue for future research.

KW - Antisense

KW - Chemosensitizer

KW - Cisplatin

KW - Multidrug resistance

KW - Prx II

UR - http://www.scopus.com/inward/record.url?scp=0037201471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037201471&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 273

EP - 277

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 4

ER -